445 related articles for article (PubMed ID: 16981687)
1. Endocannabinoid metabolism in the absence of fatty acid amide hydrolase (FAAH): discovery of phosphorylcholine derivatives of N-acyl ethanolamines.
Mulder AM; Cravatt BF
Biochemistry; 2006 Sep; 45(38):11267-77. PubMed ID: 16981687
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mice lacking candidate N-acyl ethanolamine biosynthetic enzymes provides evidence for multiple pathways that contribute to endocannabinoid production in vivo.
Simon GM; Cravatt BF
Mol Biosyst; 2010 Aug; 6(8):1411-8. PubMed ID: 20393650
[TBL] [Abstract][Full Text] [Related]
3. N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA).
Ueda N; Tsuboi K; Uyama T
Prog Lipid Res; 2010 Oct; 49(4):299-315. PubMed ID: 20152858
[TBL] [Abstract][Full Text] [Related]
4. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.
Kaczocha M; Glaser ST; Chae J; Brown DA; Deutsch DG
J Biol Chem; 2010 Jan; 285(4):2796-806. PubMed ID: 19926788
[TBL] [Abstract][Full Text] [Related]
5. Expression and secretion of N-acylethanolamine-hydrolysing acid amidase in human prostate cancer cells.
Wang J; Zhao LY; Uyama T; Tsuboi K; Wu XX; Kakehi Y; Ueda N
J Biochem; 2008 Nov; 144(5):685-90. PubMed ID: 18806270
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways.
Bradshaw HB; Rimmerman N; Hu SS; Benton VM; Stuart JM; Masuda K; Cravatt BF; O'Dell DK; Walker JM
BMC Biochem; 2009 May; 10():14. PubMed ID: 19460156
[TBL] [Abstract][Full Text] [Related]
7. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
[TBL] [Abstract][Full Text] [Related]
9. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
10. An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase.
Long JZ; LaCava M; Jin X; Cravatt BF
J Lipid Res; 2011 Feb; 52(2):337-44. PubMed ID: 21097653
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
Vandevoorde S; Fowler CJ
Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid amide hydrolase (FAAH) regulates hypercapnia/ischemia-induced increases in n-acylethanolamines in mouse brain.
Lin L; Metherel AH; Jones PJ; Bazinet RP
J Neurochem; 2017 Sep; 142(5):662-671. PubMed ID: 28488728
[TBL] [Abstract][Full Text] [Related]
14. Effect of nitric oxide donors on membrane tritium accumulation of endocannabinoids and related endogenous lipids.
Thors L; Fowler CJ
Eur J Pharmacol; 2009 Oct; 621(1-3):10-8. PubMed ID: 19715690
[TBL] [Abstract][Full Text] [Related]
15. Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance.
Balsevich G; Sticht M; Bowles NP; Singh A; Lee TTY; Li Z; Chelikani PK; Lee FS; Borgland SL; Hillard CJ; McEwen BS; Hill MN
Proc Natl Acad Sci U S A; 2018 Jul; 115(29):7605-7610. PubMed ID: 29967158
[TBL] [Abstract][Full Text] [Related]
16. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity.
Patel S; Carrier EJ; Ho WS; Rademacher DJ; Cunningham S; Reddy DS; Falck JR; Cravatt BF; Hillard CJ
J Lipid Res; 2005 Feb; 46(2):342-9. PubMed ID: 15576840
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
18. Effects of tumour necrosis factor α upon the metabolism of the endocannabinoid anandamide in prostate cancer cells.
Karlsson J; Gouveia-Figueira S; Alhouayek M; Fowler CJ
PLoS One; 2017; 12(9):e0185011. PubMed ID: 28910408
[TBL] [Abstract][Full Text] [Related]
19. Effects of synthetic alkamides on Arabidopsis fatty acid amide hydrolase activity and plant development.
Faure L; Cavazos R; Khan BR; Petros RA; Koulen P; Blancaflor EB; Chapman KD
Phytochemistry; 2015 Feb; 110():58-71. PubMed ID: 25491532
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.
Simon GM; Cravatt BF
J Biol Chem; 2006 Sep; 281(36):26465-72. PubMed ID: 16818490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]